NSF funds UNC scientists to explore potential COVID-19 aerosol transmission

August 3, 2020
In an effort to further our understanding of how COVID-19 is spread, the National Science Foundation has funded a team of researchers at the Gillings School, led by Dr. Barbara Turpin, to study the SARS-CoV-2 virus' potential for aerosol transmission.

Puertas marshals resources to combat pandemic in 26 countries

July 28, 2020
Health policy and management alumnus Dr. Benjamin Puertas enrolled in the Gillings School out of a desire to expand his capacity to make a difference, though he had already founded a school of public health and helped many patients as a medical doctor. Now he is working to train health care workers and ensure the use of best practices in fighting the COVID-19 pandemic.

Suzanne Maman named associate dean for global health

July 28, 2020
Dr. Suzanne Maman has been appointed associate dean for global health, the Gillings School’s chief global leader and liaison, responsible for evolving global strategy and global health initiatives. She will begin this role on Sept. 1.

Haddad's pandemic preparation pays off in Laos

July 14, 2020
Samuel Haddad, a 2018 UNC Gillings School nutrition alumnus, already was working in Laos with Population Services International to prepare for a public health emergency when COVID-19 began spreading on a global scale. His work there supported an effective national response to the pandemic.

Gillings faculty urge World Health Organization to address potential airborne spread of COVID-19

July 14, 2020
Drs. Barbara Turpin, Glenn Morrison and Jason Surratt from the Department of Environmental Sciences and Engineering have joined more than two hundred scientists in signing an open letter to the World Health Organization expressing concern about the potential airborne spread of COVID-19.

New study supports remdesivir as COVID-19 treatment

July 9, 2020
Researchers at the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center and Gilead Sciences report that remdesivir greatly inhibited SARS-CoV-2, the virus that causes COVID-19, in human lung cell cultures and also improved lung function in mice infected with the virus.

Seven new Gillings Innovation Labs will tackle COVID-19

July 6, 2020
Exactly how does coronavirus spread in the air? What will get kids’ vaccinations back on track across the United States? How can public health practitioners work with church communities to spread accurate information about COVID-19? These are just three of the questions being explored by Gillings School researchers and their collaborators through a special COVID-19 round of Gillings Innovation Laboratory awards.

Groundbreaking study reveals genetic markers for Type 2 diabetes in East Asians

July 6, 2020
A recent study — the largest of its kind in any non-European population — demonstrates that while different populations of people share similar genetic predispositions for Type 2 diabetes, they also have some genetic variations that can alter their susceptibility to developing the disease.

Giving a global voice to minority smoking inequities

June 22, 2020
A UNC-Chapel Hill student-led public health team places third among 3,500 participants in Oxford University’s global systems mapping competition, exploring racial and ethnic disparities in tobacco control.

Gillings alumnus Handzel named CDC’s global water, sanitation and hygiene coordinator

June 15, 2020
The United States Centers for Disease Control and Prevention (CDC) recently appointed UNC Gillings School alumnus Dr. Tom Handzel as global WASH coordinator at their Center for Global Health. (WASH stands for Water, Sanitation and Hygiene.)

...
10
11
12
1
8
9
13
14
15
16
124
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400